封面
市场调查报告书
商品编码
1770898

生物製程容器市场-全球产业规模、份额、趋势、机会和预测,按容器类型、应用、最终用户、地区和竞争情况细分,2020-2030 年

Bioprocess Containers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type of Containers, By Application, By End Users, By Region and Competition, 2020-2030F

出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球生物製程容器市场价值为 46.8 亿美元,预计到 2030 年将达到 158.7 亿美元,预测期内的复合年增长率为 22.57%。市场快速扩张的主要原因是生物製药行业越来越多地采用自动化和机器学习,以及引入支持创新治疗产品开发的先进技术。生物製程容器是药品生产中传统不銹钢系统的经济高效且可靠的替代品。它们的一次性设计提供了灵活性,降低了污染风险,并最大限度地减少了清洁要求。由于其可扩展性和运营效率,这些容器在生物製造中越来越受欢迎。最近的发展也见证了智慧感测器和基于物联网的功能的集成,进一步增强了生物加工环境中的製程监控和控制。

市场概览
预测期 2026-2030
2024年市场规模 46.8亿美元
2030年市场规模 158.7亿美元
2025-2030 年复合年增长率 22.57%
成长最快的领域 3D生物製程容器
最大的市场 北美洲

关键市场驱动因素

生物製药研发和个人化医疗的扩展

主要市场挑战

环境问题和废弃物管理

主要市场趋势

智慧科技与物联网的融合

目录

第 1 章:产品概述

第二章:研究方法

第三章:执行摘要

第四章:顾客之声

第五章:全球生物工艺容器市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 依容器类型(2D 生物製程容器、3D 生物製程容器、其他容器及配件)
    • 按应用(上游製程、下游製程、製程开发)
    • 按最终用户(生物製药公司、生命科学研发公司、其他)
    • 按地区(北美、欧洲、亚太、南美、中东和非洲)
    • 按公司分类(2024)
  • 市场地图
  • 依货柜类型
  • 按应用
  • 按最终用户
  • 按地区

第六章:北美生物製程容器市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 北美:国家分析
    • 美国
    • 加拿大
    • 墨西哥

第七章:欧洲生物工艺容器市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 欧洲:国家分析
    • 法国
    • 德国
    • 英国
    • 义大利
    • 西班牙

第八章:亚太生物製程容器市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 亚太地区:国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章:南美洲生物工艺容器市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 南美洲:国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第十章:中东与非洲生物製程容器市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • MEA:国家分析
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第 11 章:市场动态

  • 驱动程式
  • 挑战

第 12 章:市场趋势与发展

  • 近期发展
  • 併购
  • 产品发布

第 13 章:全球生物製程容器市场:SWOT 分析

第 14 章:波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 顾客的力量
  • 替代产品的威胁

第 15 章:竞争格局

  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Saint-Gobain Group
  • Lonza Group AG
  • Avantor Funding Inc.
  • Merck KGaA
  • Sartorius AG
  • CellBios Healthcare and Lifesciences Pvt Ltd.
  • Cole-Parmer Instrument Co.
  • Biomass Ventures Pte Ltd.

第 16 章:策略建议

第17章调查会社について・免责事项

简介目录
Product Code: 15113

The Global Bioprocess Containers Market was valued at USD 4.68 billion in 2024 and is projected to reach USD 15.87 billion by 2030, growing at a CAGR of 22.57% during the forecast period. The market's rapid expansion is primarily driven by the increasing adoption of automation and machine learning within the biopharmaceutical sector, alongside the introduction of advanced technologies supporting the development of innovative therapeutic products. Bioprocess containers serve as a cost-efficient and reliable alternative to traditional stainless-steel systems in drug manufacturing. Their single-use design offers flexibility, reduces contamination risk, and minimizes cleaning requirements. These containers are increasingly favored in biomanufacturing due to their scalability and operational efficiency. Recent developments have also seen the integration of smart sensors and IoT-based functionalities, further enhancing process monitoring and control within bioprocessing environments.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 4.68 Billion
Market Size 2030USD 15.87 Billion
CAGR 2025-203022.57%
Fastest Growing Segment3D Bioprocess Containers
Largest MarketNorth America

Key Market Drivers

Expansion of Biopharmaceutical R&D and Personalized Medicine

The growing investment in biopharmaceutical research and personalized medicine is a major driver fueling demand for bioprocess containers. These containers, particularly single-use systems, offer key advantages such as reduced contamination risk, scalability, and operational flexibility-features essential for the evolving needs of biopharmaceutical production.

Significant funding initiatives are supporting this trend. In 2024, the U.S. National Institutes of Health (NIH) allocated over $47 billion to medical research, focusing on gene therapies and personalized treatments. Likewise, the European Union's Horizon Europe program earmarked €95.5 billion for innovation and health research between 2021 and 2027.

These investments are catalyzing the development of complex biologics, including monoclonal antibodies, cell therapies, and vaccines. Bioprocess containers play a vital role in this space, offering sterile, disposable solutions that help accelerate production timelines and reduce cross-contamination, thus supporting the efficient delivery of personalized medical solutions.

Key Market Challenges

Environmental Concerns and Waste Management

Despite operational advantages, the single-use nature of bioprocess containers presents a significant environmental challenge due to the generation of plastic-based biomedical waste. The disposal of these materials raises sustainability concerns across the biopharmaceutical industry.

Global regulatory bodies are placing increased emphasis on sustainable manufacturing. For example, the European Union has enacted directives to reduce plastic waste and promote recyclable or biodegradable alternatives. In the United States, the Environmental Protection Agency (EPA) is driving initiatives to manage plastic waste and encourage eco-friendly practices.

However, recycling bioprocess containers remains complex due to contamination risks and material limitations. The lack of standardized disposal protocols and viable recycling infrastructure makes it difficult for manufacturers to meet environmental compliance goals. As a result, the market faces mounting pressure to develop innovative materials and waste mitigation strategies that align with growing sustainability expectations.

Key Market Trends

Integration of Smart Technologies and IoT

The incorporation of smart technologies and IoT into bioprocess containers is transforming modern biomanufacturing. Smart containers equipped with real-time sensors and digital connectivity are enabling manufacturers to monitor critical process parameters such as temperature, pH, and pressure with high precision.

Governmental support for digital innovation in manufacturing is reinforcing this trend. The U.S. Department of Commerce's NIST and the European Commission's Industry 5.0 initiative both promote the adoption of intelligent systems to enhance industrial efficiency and adaptability.

This movement aligns with the broader evolution toward Industry 4.0, where automation, data analytics, and machine-to-machine communication are key drivers of operational excellence. Smart bioprocess containers enable predictive maintenance, improve traceability, reduce downtime, and support regulatory compliance-collectively enhancing product quality and manufacturing efficiency.

Key Market Players

  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Saint-Gobain Group
  • Lonza Group AG
  • Avantor Funding Inc.
  • Merck KGaA
  • Sartorius AG
  • CellBios Healthcare and Lifesciences Pvt Ltd.
  • Cole-Parmer Instrument Co.
  • Biomass Ventures Pte Ltd.

Report Scope:

In this report, the Global Bioprocess Containers Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bioprocess Containers Market, By Type of Containers:

  • 2D Bioprocess Containers
  • 3D Bioprocess Containers
  • Other Containers and Accessories

Bioprocess Containers Market, By Application:

  • Upstream Process
  • Downstream Process
  • Process Development

Bioprocess Containers Market, By End Users:

  • Biopharmaceutical Companies
  • Life Science R&D Companies
  • Others

Bioprocess Containers Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • India
    • South Korea
    • Japan
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Bioprocess Containers Market.

Available Customizations:

Global Bioprocess Containers Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Bioprocess Containers Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type of Containers (2D Bioprocess Containers, 3D Bioprocess Containers, Other Containers and Accessories)
    • 5.2.2. By Application (Upstream Process, Downstream Process, Process Development)
    • 5.2.3. By End Users (Biopharmaceutical Companies, Life Science R&D Companies, Others)
    • 5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
    • 5.2.5. By Company (2024)
  • 5.3. Market Map
  • 5.3.1 By Type of Containers
  • 5.3.2 By Application
  • 5.3.3 By End Users
  • 5.3.4 By Region

6. North America Bioprocess Containers Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type of Containers (2D Bioprocess Containers, 3D Bioprocess Containers, Other Containers and Accessories)
    • 6.2.2. By Application (Upstream Process, Downstream Process, Process Development)
    • 6.2.3. By End Users (Biopharmaceutical Companies, Life Science R&D Companies, Others)
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Bioprocess Containers Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type of Containers
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Bioprocess Containers Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type of Containers
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Bioprocess Containers Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type of Containers
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User

7. Europe Bioprocess Containers Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type of Containers (2D Bioprocess Containers, 3D Bioprocess Containers, Other Containers and Accessories)
    • 7.2.2. By Application (Upstream Process, Downstream Process, Process Development)
    • 7.2.3. By End Users (Biopharmaceutical Companies, Life Science R&D Companies, Others)
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Bioprocess Containers Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type of Containers
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. Germany Bioprocess Containers Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type of Containers
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Bioprocess Containers Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type of Containers
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Bioprocess Containers Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type of Containers
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Bioprocess Containers Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type of Containers
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End User

8. Asia-Pacific Bioprocess Containers Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type of Containers (2D Bioprocess Containers, 3D Bioprocess Containers, Other Containers and Accessories)
    • 8.2.2. By Application (Upstream Process, Downstream Process, Process Development)
    • 8.2.3. By End Users (Biopharmaceutical Companies, Life Science R&D Companies, Others)
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Bioprocess Containers Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type of Containers
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. India Bioprocess Containers Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type of Containers
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Bioprocess Containers Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type of Containers
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Bioprocess Containers Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type of Containers
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Bioprocess Containers Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type of Containers
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. South America Bioprocess Containers Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type of Containers (2D Bioprocess Containers, 3D Bioprocess Containers, Other Containers and Accessories)
    • 9.2.2. By Application (Upstream Process, Downstream Process, Process Development)
    • 9.2.3. By End Users (Biopharmaceutical Companies, Life Science R&D Companies, Others)
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Bioprocess Containers Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type of Containers
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. Argentina Bioprocess Containers Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type of Containers
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. Colombia Bioprocess Containers Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type of Containers
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User

10. Middle East and Africa Bioprocess Containers Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type of Containers (2D Bioprocess Containers, 3D Bioprocess Containers, Other Containers and Accessories)
    • 10.2.2. By Application (Upstream Process, Downstream Process, Process Development)
    • 10.2.3. By End Users (Biopharmaceutical Companies, Life Science R&D Companies, Others)
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Bioprocess Containers Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type of Containers
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Saudi Arabia Bioprocess Containers Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type of Containers
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. UAE Bioprocess Containers Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type of Containers
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Bioprocess Containers Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Thermo Fisher Scientific Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Danaher Corporation
  • 15.3. Saint-Gobain Group
  • 15.4. Lonza Group AG
  • 15.5. Avantor Funding Inc.
  • 15.6. Merck KGaA
  • 15.7. Sartorius AG
  • 15.8. CellBios Healthcare and Lifesciences Pvt Ltd.
  • 15.9. Cole-Parmer Instrument Co.
  • 15.10. Biomass Ventures Pte Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer